Venlafaxine Hydrochloride
Product Images NDC 50090-5929

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-5929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (310c558f 5135 4ddd B0bd F993c0ea8d62 01)

A pharmacokinetic (PK) fold change chart showing interactions of venlafaxine hydrochloride with various drugs. The X-axis represents change relative to a reference value, and the Y-axis lists interacting drugs such as Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The chart includes PK parameters like Cmax and AUC for venlafaxine and its ODV analyte, with recommendations such as avoiding concomitant use or using with caution for specific interacting drugs.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (310c558f 5135 4ddd B0bd F993c0ea8d62 02)

A forest plot chart showing the fold change in pharmacokinetic analytes (Cmax and AUC) for various interacting drugs with venlafaxine hydrochloride, including ethanol, diazepam, alprazolam, indinavir, metaprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The chart includes recommendations such as dose adjustment advice and clinical significance notes.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (310c558f 5135 4ddd B0bd F993c0ea8d62 03)

A chart displaying fold change and 90% confidence intervals for venlafaxine and its metabolite ODV in various special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism, age over 60 years, and gender differences. The chart relates pharmacokinetic parameters Cmax and AUC to dose adjustment recommendations.*

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (310c558f 5135 4ddd B0bd F993c0ea8d62 04)

Chemical structure of venlafaxine hydrochloride showing its molecular components including a cyclohexane ring, hydroxyl group, and dimethylamine moiety, with the hydrochloride indicated as a separate component.*

FDA Label Image

Label Image (Lbl500905929)

Label for venlafaxine hydrochloride 37.5 mg extended-release capsules by A-S Medication Solutions. The label includes product number 6468-0, storage instructions (store at 40 to 70 degrees F), packaging details (30 extended-release capsules), and notes that the capsules contain venlafaxine hydrochloride equivalent to venlafaxine 37.5 mg. The label also shows the NDC 50090-5929-0 and the location of the labeler in Libertyville, Illinois.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.